U.S. markets closed

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.50+0.35 (+2.47%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/23/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) -0.07
52-Week Change 3-27.82%
S&P500 52-Week Change 336.19%
52 Week High 324.70
52 Week Low 313.00
50-Day Moving Average 314.29
200-Day Moving Average 317.35

Share Statistics

Avg Vol (3 month) 3391.31k
Avg Vol (10 day) 3333.44k
Shares Outstanding 532.32M
Implied Shares Outstanding 668.33M
Float 26.67M
% Held by Insiders 14.39%
% Held by Institutions 192.47%
Shares Short (Jun 29, 2021) 44.68M
Short Ratio (Jun 29, 2021) 49.23
Short % of Float (Jun 29, 2021) 416.18%
Short % of Shares Outstanding (Jun 29, 2021) 46.84%
Shares Short (prior month May 27, 2021) 44.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.24%
Return on Equity (ttm)-77.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -175.14M
Net Income Avi to Common (ttm)-184.45M
Diluted EPS (ttm)-2.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)264.02M
Total Cash Per Share (mrq)3.86
Total Debt (mrq)6.57M
Total Debt/Equity (mrq)2.43
Current Ratio (mrq)7.77
Book Value Per Share (mrq)3.96

Cash Flow Statement

Operating Cash Flow (ttm)-144.86M
Levered Free Cash Flow (ttm)-92.25M